Form 4: Checkpoint Therapeutics CEO James Oliviero Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO James Oliviero sold shares of Checkpoint Therapeutics stock to cover tax obligations related to the vesting of restricted shares.
Summary
- James F. Oliviero III, CEO, President, and Director of Checkpoint Therapeutics, Inc., sold shares of common stock on February 7, 2025, and February 10, 2025, to cover tax obligations related to vesting restricted shares.
- On February 7, 2025, 9,233 shares were sold at a weighted average price of $3.41, with prices ranging from $3.40 to $3.41.
- On February 10, 2025, 10,331 shares were sold at a weighted average price of $3.15, with prices ranging from $3.14 to $3.16.
- Following these transactions, Oliviero directly owns 3,775,019 shares of Checkpoint Therapeutics, Inc., which includes restricted common stock vesting over various time periods.
- The sales were executed automatically by the company's restricted stock administrator according to corporate policies.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing indicates routine transactions to cover tax obligations, which is a normal part of executive compensation. There's no indication of a change in the company's prospects or management's confidence.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation plans and are not necessarily indicative of a negative outlook on the company.
Stakeholder Impact
- The stock sales could have a minor, temporary impact on the stock price due to increased selling pressure.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | James Oliviero sold 9,233 shares of common stock at a weighted average price of $3.41. |
| 02/10/2025 | James Oliviero sold 10,331 shares of common stock at a weighted average price of $3.15. |
| 02/11/2025 | Date of signature for the SEC Form 4 filing. |
Keywords
Checkpoint Therapeutics, James Oliviero, stock sale, Form 4, SEC filing, insider trading, CKPT, restricted stock, tax obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.